Imputing the Number of Responders from the Mean and Standard Deviation of CGI-Improvement in Clinical Trials Investigating Medications for Autism Spectrum Disorder

A white paper on a neurodevelopmental framework for drug discovery in autism and other neurodevelopmental disorders

(2021) CM Díaz-Caneja et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysis

(2020) Spyridon Siafis et al.   Molecular Autism

Seriously misleading results using inverse of Freeman‐Tukey double arcsine transformation in meta‐analysis of single proportions

(2019) Guido Schwarzer et al.   Research Synthesis Methods

Do clinicians understand the size of treatment effects? A randomized survey across 8 countries

(2015) Bradley C. Johnston et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Meta-analysis in clinical trials revisited

(2015) Rebecca DerSimonian et al.   Contemporary Clinical Trials

Systematic review of tools to measure outcomes for young children with autism spectrum disorder

(2015) Helen McConachie et al.   HEALTH TECHNOLOGY ASSESSMENT

Odds ratios of treatment response were well approximated from continuous rating scale scores for meta-analysis

(2015) Ramona Meister et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Conducting Meta-Analyses inRwith themetaforPackage

(2015) Wolfgang Viechtbauer   Journal of Statistical Software

Imputation of response rates from means and standard deviations in schizophrenia

(2013) Myrto T. Samara et al.   SCHIZOPHRENIA RESEARCH

Relative indices of treatment effect may be constant across different definitions of response in schizophrenia trials

(2010) Toshi A. Furukawa et al.   SCHIZOPHRENIA RESEARCH

Lack of Efficacy of Citalopram in Children With Autism Spectrum Disorders and High Levels of Repetitive Behavior

(2009) Bryan H. King et al.   ARCHIVES OF GENERAL PSYCHIATRY